OCUL

Ocular Therapeutix, Inc.

7.84 USD
-0.01 (-0.13%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Ocular Therapeutix, Inc. stock is up 25.44% since 30 days ago. The next earnings date is Aug 5, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 40% of the previous 10 July’s closed higher than June. In the last 5 Unusual Options Trades, there were 2 CALLs, 3 PUTs.

Options Flow Last 10
Date & Time Expiration Date Strike Price Trade Type Size Open Interest
22 May 16:41 20 Sep, 2024 7.50 CALL 400 392
24 May 17:51 17 Jan, 2025 3.50 PUT 300 302
03 Jun 13:35 16 Jan, 2026 10.00 PUT 100 92
14 Jun 19:54 21 Jun, 2024 4.00 CALL 300 355
20 Jun 18:10 17 Jan, 2025 7.00 PUT 150 208

About Ocular Therapeutix, Inc.

Ocular Therapeutix, Inc. focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cataract surgery. It is also developing OTX-TKI, an axitinib intravitreal implant that is in phase 1 clinical trials for the treatment of wet age-related macular degeneration and other retinal diseases.